Subscribe To
Mps ii and beyond: implications of denali's promising pipeline
Denali Therapeutics is a promising underdog in the biotech sector, focusing on neurodegenerative diseas...
July 23, 2023, 12:51 am
Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model
Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...
June 24, 2023, 12:00 pm
Alterity therapeutics to present in mst access rare diseases, rich returns forum on 22 june 2023
MELBOURNE, Australia and SAN FRANCISCO, June 21, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Com...
June 21, 2023, 7:25 am
Anavex life sciences to present at the h.c. wainwright 4th annual neuropsychiatry virtual conference
NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmac...
June 20, 2023, 7:30 am
Clene announces launch of proposed public offering
SALT LAKE CITY, June 15, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), along with its subsidiaries “Clene” and its wholly owned subsidiary ...
June 15, 2023, 8:38 pm
Alterity therapeutics ceo david stamler to present at the share series monday management update on monday, may 22, 2023
MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics, a biotechnology company dedicated to developing diseas...
May 19, 2023, 7:25 am
Biovie aims to treat parkinson's and alzheimer's by focusing on inflammation
By targeting inflammation as a novel pathway, clinical-stage biotechnology company BioVie Inc (NASDAQ:BIVI) aims to discover treatments for neurologic...
May 16, 2023, 8:01 am
Why shares of denali therapeutics are up monday
Denali released first-quarter earnings last week. The company focuses on therapies to treat neurodegenerative<...
May 15, 2023, 4:31 pm
Amylyx: a biotech underdog's resilient performance and promising market potential
Amylyx Pharmaceuticals, a biotech firm focusing on neurodegenerative disorders, has seen impressive Q1 ...
May 15, 2023, 5:40 am
Brainstorm to announce first quarter 2023 financial results and provide a corporate update
NEW YORK , May 9, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for ...
May 9, 2023, 6:00 am
Centogene to participate in upcoming conferences in may
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 05, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner f...
May 5, 2023, 6:30 am
Vyant bio announces filing of form 25 for voluntary nasdaq delisting and sec deregistration
CHERRY HILL, N.J., May 04, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is a biotechnology company that...
May 4, 2023, 8:30 pm
Anavex life sciences to announce fiscal 2023 second quarter financial results on tuesday, may 9, 2023
Webcast and Conference Call To be Held Tuesday, May 9, 2023, 8:30 am ET NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Ana...
May 2, 2023, 11:30 am
Rumi scientific announces data demonstrating disease modifying effect of brd9 inhibition in a huntington’s disease animal model
Data presented at the CHDI Foundation 18th Annual Huntington’s Disease Therapeutics Conference NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) — Rumi Sc...
April 26, 2023, 11:05 am
Anavex life sciences to present at the h.c. wainwright bioconnect investor conference at nasdaq
NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharm...
April 25, 2023, 11:30 am
Biovie to present phase 2 trial data abstracts at 2023 american academy of neurology annual meeting
BioVie announced that data abstracts from its Phase 2 trials evaluating NE3107 in degenerative dementias and Parkinson's disease will be presented at ...
April 17, 2023, 12:01 pm
Nkgen biotech, inc. to become publicly traded company via business combination with graf acquisition corp. iv
NKGen Biotech, Inc. (“NKGen”), a clinical stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with Graf Acquisitio...
April 15, 2023, 12:19 am
Tiziana life sciences says intranasal foralumab presented at ‘preserving the brain' scientific conference and exhibit in shanghai
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that poster presentations on intranasal foralumab are being presented at the ‘Preserving the B...
April 10, 2023, 8:08 am
Anavex life sciences to present at the 22nd annual needham virtual healthcare conference 2023
NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharma...
April 10, 2023, 7:00 am
Annovis and buntanetap: asymmetric risk/reward ahead of parkinson's data readout
Lead asset buntanetap represents a differentiated, potentially disease-modifying mechanism of action in neurod...
March 30, 2023, 12:00 pm